Why BioXcel Therapeutics Shares Are Rising Tuesday
BioXcel Therapeutics shares surge 25.1% as the company terminates its proposed public offering and shifts focus to upcoming FDA meeting and Phase 3 trial.
BIOLASE, Inc. Announces Pricing Of $7M Public Offering Of 16M Units At A Price Of $0.44/Unit
BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today announced the pricing of its public offering of 16,000,000 units, with each unit consisting of one share of common stock (or one pre-funded warrant
Gates Announces Pricing Of Secondary Offering Of 17.5M Ordinary Shares
Gates Industrial Corporation plc (NYSE:GTES, ", Gates", or the ", Company", )))) announced today the pricing of the previously announced secondary offering of 17,500,000 ordinary shares (the "Offering") by certain
Sunshine Biopharma, Inc. Announces Pricing Of $10M Underwritten Public Offering
Sunshine Biopharma, Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals, today announced the
What’s Going On With Vuzix Stock Monday?
After the market close on Friday, Vuzix announced that it may from time to time sell common stock, preferred stock, warrants, or a combination of securities in one or more offerings for an aggregate initial offering price of up to $300 million.
Why BioXcel Therapeutics Shares Are Falling Today
BioXcel Therapeutics sees a dip in shares as it launches a $60 million public offering to fund clinical trials and corporate needs.
1847 Holdings LLC Announces Pricing Of $5M Public Offering Of 5M Shares And/Or Pre-Funded Warrants In Lieu Of Shares, Priced At A Public Offering Price Of $1/Share Or Pre-Funded Warrant
1847 Holdings LLC (NYSE:EFSH) ("1847 Holdings" or the "Company"), a unique holding company that combines the attractive attributes of owning private, lower-middle market businesses with the liquidity and transparency of
Evoke Pharma Has Priced An Underwritten Public Offering Led By Nantahala Capital Management For Gross Proceeds Of Up To $30M Million, Which Includes Initial Upfront Funding Of Approximately $7.5M
The offering is comprised of (i) 11,029,411 shares of common stock (or pre-funded warrants in lieu thereof), (ii) 11,029,411 Series A Warrants with an initial exercise price of $0.68 per share and a term of
Tenaya Therapeutics Announces Pricing Of $50M Underwritten Offering Of 8,888,890 Shares Of Its Common Stock At An Offering Price Of $4.50 Per Share
Tenaya Therapeutics, Inc. (NASDAQ:TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today
What’s Going On With Trump-Linked Phunware Stock Today?
Phunware launched a $10 million public offering on Wednesday. The company said it plans to offer and sell 40 million shares of its common stock at a price of 25 cents per share. All of the shares are being offered by Phunware.